Constellation Pharmaceuticals (CNST) Short Interest Ratio & Short Volume → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free CNST Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Constellation Pharmaceuticals Short Interest DataCurrent Short Volume2,520,000 sharesPrevious Short Volume3,520,000 sharesChange Vs. Previous Month-28.41%Dollar Volume Sold Short$85.18 millionShort Interest Ratio / Days to Cover1.8Last Record DateJune 30, 2021Outstanding Shares47,915,000 sharesFloat Size37,330,000 sharesShort Percent of Float6.75%Today's Trading Volume0 sharesAverage Trading Volume940,325 sharesToday's Volume Vs. Average0% Short Selling Constellation Pharmaceuticals ? Sign up to receive the latest short interest report for Constellation Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCNST Short Interest Over TimeCNST Days to Cover Over TimeCNST Percentage of Float Shorted Over Time Ad Stansberry ResearchMove Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. Constellation Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/20212,520,000 shares $85.18 million -28.4%6.8%1.8 $33.80 6/15/20213,520,000 shares $118.73 million -53.7%9.4%2.6 $33.73 5/28/20217,600,000 shares $150.56 million -0.7%20.4%6.2 $19.81 5/14/20217,650,000 shares $146.88 million +17.5%N/A16.9 $19.20 4/30/20216,510,000 shares $138.53 million +0.6%N/A14.5 $21.28 4/15/20216,470,000 shares $149.33 million -1.7%N/A14.9 $23.08 Get the Latest News and Ratings for CNST and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Constellation Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 3/31/20216,580,000 shares $153.91 million +8.9%N/A14.3 $23.39 3/15/20216,040,000 shares $181.38 million -1.2%N/A11.4 $30.03 2/26/20216,110,000 shares $163.20 million +5.5%N/A10 $26.71 2/12/20215,790,000 shares $201.32 million -1.0%N/A9.6 $34.77 1/29/20215,850,000 shares $198.32 million +3.0%N/A9.7 $33.90 1/15/20215,680,000 shares $168.53 million +7.2%N/A8.3 $29.67 12/31/20205,300,000 shares $160.06 million No ChangeN/A8.2 $30.20 12/15/20205,300,000 shares $167.56 million -7.8%N/A8.2 $31.62 11/30/20205,750,000 shares $148.29 million +5.1%N/A9.3 $25.79 11/15/20205,470,000 shares $114.87 million -7.3%N/A9.5 $21.00 10/30/20205,900,000 shares $110.39 million +5.7%N/A10.8 $18.71 10/15/20205,580,000 shares $124.71 million +12.5%N/A10.7 $22.35 9/30/20204,960,000 shares $100.49 million +30.5%N/A9.1 $20.26 9/15/20203,800,000 shares $89.34 million +5.6%N/A6.6 $23.51 8/31/20203,600,000 shares $75.78 million -15.5%N/A5.4 $21.05 8/14/20204,260,000 shares $97.98 million -13.8%N/A6.3 $23.00 7/31/20204,940,000 shares $132.84 million +6.7%N/A7 $26.89 7/15/20204,630,000 shares $132.23 million +10.5%N/A6.9 $28.56 6/30/20204,190,000 shares $119.96 million +107.4%N/A6.5 $28.63 6/15/20202,020,000 shares $76.19 million +28.7%N/A3.5 $37.72 5/29/20201,570,000 shares $55.78 million +37.7%6.1%3.5 $35.53 5/15/20201,140,000 shares $49.45 million -35.6%4.5%2.6 $43.38 4/30/20201,770,000 shares $63.68 million -11.9%7.7%4.7 $35.98 4/15/20202,010,000 shares $68.46 million +0.5%8.7%5.9 $34.06 3/31/20202,000,000 shares $74.60 million -4.3%8.7%5.4 $37.30 3/13/20202,090,000 shares $71.39 million +2.0%9.1%5.4 $34.16 2/28/20202,050,000 shares $59.35 million +10.2%9.0%3.9 $28.95 2/14/20201,860,000 shares $60.28 million +18.5%8.2%3.3 $32.41 1/31/20201,570,000 shares $55.19 million -6.0%11.2%2.6 $35.15 1/15/20201,670,000 shares $58.15 million -7.7%11.9%2.3 $34.82 12/31/20191,810,000 shares $66.26 million No Change13.2%2.5 $36.61 8/15/20191,115,400 shares $8.42 million 0.0%10.0%17.7 $7.55 CNST Short Interest - Frequently Asked Questions What is Constellation Pharmaceuticals' current short interest? Short interest is the volume of Constellation Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of June 30th, traders have sold 2,520,000 shares of CNST short. 6.75% of Constellation Pharmaceuticals' shares are currently sold short. Learn More on Constellation Pharmaceuticals' current short interest. What is a good short interest ratio for Constellation Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CNST shares currently have a short interest ratio of 2.0. Learn More on Constellation Pharmaceuticals's short interest ratio. What is a good short interest percentage for Constellation Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.75% of Constellation Pharmaceuticals' floating shares are currently sold short. Is Constellation Pharmaceuticals' short interest increasing or decreasing? Constellation Pharmaceuticals saw a drop in short interest during the month of June. As of June 30th, there was short interest totaling 2,520,000 shares, a drop of 28.4% from the previous total of 3,520,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Constellation Pharmaceuticals' float size? Constellation Pharmaceuticals currently has issued a total of 47,915,000 shares. Some of Constellation Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Constellation Pharmaceuticals currently has a public float of 37,330,000 shares. How does Constellation Pharmaceuticals' short interest compare to its competitors? 6.75% of Constellation Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Constellation Pharmaceuticals: Harmony Biosciences Holdings, Inc. (21.01%), Avadel Pharmaceuticals plc (11.71%), Supernus Pharmaceuticals, Inc. (8.93%), Amneal Pharmaceuticals, Inc. (2.51%), Taro Pharmaceutical Industries Ltd. (0.58%), Structure Therapeutics Inc. (9.92%), Protagonist Therapeutics, Inc. (6.04%), Dynavax Technologies Co. (14.17%), Catalyst Pharmaceuticals, Inc. (6.18%), Zai Lab Limited (4.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($8.32 billion), AstraZeneca PLC ($8.20 billion), Block, Inc. ($7.79 billion), Analog Devices, Inc. ($7.16 billion), S&P Global Inc. ($7.07 billion), Aon plc ($6.17 billion), Charter Communications, Inc. ($5.38 billion), Wayfair Inc. ($4.80 billion), AMC Entertainment Holdings, Inc. ($4.28 billion), and Snowflake Inc. ($3.19 billion). View all of the most shorted stocks. What does it mean to sell short Constellation Pharmaceuticals stock? Short selling CNST is an investing strategy that aims to generate trading profit from Constellation Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Constellation Pharmaceuticals? A short squeeze for Constellation Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CNST, which in turn drives the price of the stock up even further. How often is Constellation Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CNST, twice per month. The most recent reporting period available is June, 30 2021. More Short Interest Resources from MarketBeat Related Companies: Harmony Biosciences Short Interest Data Avadel Pharmaceuticals Short Interest Data Supernus Pharmaceuticals Short Interest Data Amneal Pharmaceuticals Short Interest Data Taro Pharmaceutical Industries Short Interest Data Structure Therapeutics Short Interest Data Protagonist Therapeutics Short Interest Data Dynavax Technologies Short Interest Data Catalyst Pharmaceuticals Short Interest Data Zai Lab Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CNST) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”Altimetry